FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3198163674> ?p ?o ?g. }

• W3198163674 endingPage "3164" @default.
• W3198163674 startingPage "3155" @default.
• W3198163674 abstract "The portfolio of hyaluronic acid (HA) fillers and the techniques of administration have evolved in recent years. The latest innovation in the Vycross® range was the introduction of VYC-25L (Juvéderm Volux® ; Allergan plc), a first-in-class filler effective for chin and facial lower third remodeling. The aim here was to provide clinicians who are starting to use VYC-25L with key advice, and to standardize procedures so that optimal and predictable outcomes can be obtained.A multidisciplinary group of experts in esthetic medicine from Spain and Portugal reviewed the properties, treatment paradigms, administration techniques, and potential complications of VYC-25L, on the basis of which they drafted consensus recommendations for its clinical use.The consensus panel provided specific recommendations focusing on the patient profile, dose, administration techniques, and the complications of VYC-25L and their management. The panel identified five different profiles of patients who may benefit from VYC-25L, and they drafted recommendations aimed to facilitate the treatment of these patients, namely, microgenia (women/men), masculinization (men), rejuvenation (women/men), facial laxity (women/men), and submental convexity (women/men). In terms of their safety, no specific recommendations were made beyond those established for other HA fillers.The evolution of esthetic medicine makes it necessary to update the clinical recommendations that guide patient assessment and treatment with the new HA fillers developed. The current consensus document addresses relevant issues related to the use of VYC-25L on different types of patient, in an attempt to standardize procedures and help specialists obtain predictable results." @default.
• W3198163674 created "2021-09-13" @default.
• W3198163674 creator A5000629476 @default.
• W3198163674 creator A5011112736 @default.
• W3198163674 creator A5027457494 @default.
• W3198163674 creator A5032685658 @default.
• W3198163674 creator A5048172560 @default.
• W3198163674 creator A5057202956 @default.
• W3198163674 creator A5059286155 @default.
• W3198163674 creator A5063606816 @default.
• W3198163674 creator A5075513842 @default.
• W3198163674 creator A5083510655 @default.
• W3198163674 creator A5084239022 @default.
• W3198163674 date "2021-08-30" @default.
• W3198163674 modified "2023-10-12" @default.
• W3198163674 title "An expert consensus report on the clinical use of the Vycross ^® hyaluronic acid VYC‐25 L filler" @default.
• W3198163674 cites W1511131714 @default.
• W3198163674 cites W155583464 @default.
• W3198163674 cites W1558209096 @default.
• W3198163674 cites W188836881 @default.
• W3198163674 cites W1971758461 @default.
• W3198163674 cites W2005680467 @default.
• W3198163674 cites W2014565104 @default.
• W3198163674 cites W2019945361 @default.
• W3198163674 cites W2026767134 @default.
• W3198163674 cites W2027964881 @default.
• W3198163674 cites W2101842736 @default.
• W3198163674 cites W2139750861 @default.
• W3198163674 cites W2162513921 @default.
• W3198163674 cites W2167689353 @default.
• W3198163674 cites W2192912821 @default.
• W3198163674 cites W2208768225 @default.
• W3198163674 cites W2358754135 @default.
• W3198163674 cites W2607428940 @default.
• W3198163674 cites W2782442729 @default.
• W3198163674 cites W2790357626 @default.
• W3198163674 cites W2793464666 @default.
• W3198163674 cites W2898654288 @default.
• W3198163674 cites W2926309160 @default.
• W3198163674 cites W2946517909 @default.
• W3198163674 cites W2979660401 @default.
• W3198163674 cites W3001193522 @default.
• W3198163674 cites W3026914298 @default.
• W3198163674 cites W3037886378 @default.
• W3198163674 cites W3039380437 @default.
• W3198163674 cites W3047529812 @default.
• W3198163674 cites W3092208729 @default.
• W3198163674 cites W3198163674 @default.
• W3198163674 cites W4234807945 @default.
• W3198163674 cites W4243231451 @default.
• W3198163674 cites W4301263623 @default.
• W3198163674 cites W4313462075 @default.
• W3198163674 cites W4367329919 @default.
• W3198163674 cites W990936862 @default.
• W3198163674 doi "https://doi.org/10.1111/jocd.14398" @default.
• W3198163674 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34460984" @default.
• W3198163674 hasPublicationYear "2021" @default.
• W3198163674 type Work @default.
• W3198163674 sameAs 3198163674 @default.
• W3198163674 citedByCount "3" @default.
• W3198163674 countsByYear W31981636742021 @default.
• W3198163674 countsByYear W31981636742022 @default.
• W3198163674 countsByYear W31981636742023 @default.
• W3198163674 crossrefType "journal-article" @default.
• W3198163674 hasAuthorship W3198163674A5000629476 @default.
• W3198163674 hasAuthorship W3198163674A5011112736 @default.
• W3198163674 hasAuthorship W3198163674A5027457494 @default.
• W3198163674 hasAuthorship W3198163674A5032685658 @default.
• W3198163674 hasAuthorship W3198163674A5048172560 @default.
• W3198163674 hasAuthorship W3198163674A5057202956 @default.
• W3198163674 hasAuthorship W3198163674A5059286155 @default.
• W3198163674 hasAuthorship W3198163674A5063606816 @default.
• W3198163674 hasAuthorship W3198163674A5075513842 @default.
• W3198163674 hasAuthorship W3198163674A5083510655 @default.
• W3198163674 hasAuthorship W3198163674A5084239022 @default.
• W3198163674 hasBestOaLocation W31981636742 @default.
• W3198163674 hasConcept C105702510 @default.
• W3198163674 hasConcept C159985019 @default.
• W3198163674 hasConcept C17744445 @default.
• W3198163674 hasConcept C1862650 @default.
• W3198163674 hasConcept C192562407 @default.
• W3198163674 hasConcept C199539241 @default.
• W3198163674 hasConcept C2778223994 @default.
• W3198163674 hasConcept C2779473830 @default.
• W3198163674 hasConcept C2779881321 @default.
• W3198163674 hasConcept C71924100 @default.
• W3198163674 hasConceptScore W3198163674C105702510 @default.
• W3198163674 hasConceptScore W3198163674C159985019 @default.
• W3198163674 hasConceptScore W3198163674C17744445 @default.
• W3198163674 hasConceptScore W3198163674C1862650 @default.
• W3198163674 hasConceptScore W3198163674C192562407 @default.
• W3198163674 hasConceptScore W3198163674C199539241 @default.
• W3198163674 hasConceptScore W3198163674C2778223994 @default.
• W3198163674 hasConceptScore W3198163674C2779473830 @default.
• W3198163674 hasConceptScore W3198163674C2779881321 @default.
• W3198163674 hasConceptScore W3198163674C71924100 @default.
• W3198163674 hasFunder F4320332585 @default.
• W3198163674 hasIssue "10" @default.

• next